BOSTON, MASSACHUSETTS--(Marketwire - November 05, 2007) - Advanced Proteome Therapeutics Inc. - (APT), a subsidiary of Advanced Proteome Therapeutics Corporation (TSX VENTURE: APC) and Atreus Pharmaceuticals, Inc. (Atreus) today announced they have entered into a strategic research and development agreement to explore the development of novel protein - in vivo imaging agents using advanced site-directed peptide modification techniques developed by APT.
